Cell Medica, a company active in the development, manufacture and marketing of personalised cellular immunotherapeutics for the treatment of cancer, has appointed Chris Nowers as Chief Executive Officer and Executive Director.
https://european-biotechnology.com/wp-content/uploads/2024/04/eb_appointments_chrisNowers.jpg550550Michael Kuhrt/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMichael Kuhrt2018-08-02 07:14:002018-08-02 07:14:00Cell Medica Appoints New CEO
Antiviral drug discovery company ReViral announced the successful completion of a of a US$55m Series B financing. The funding will go toward clinical studies for its respiratory tract infection treatment.
The global market value of biodegradable plastics has passed the US$1.1bn mark in 2018, a report by IHS Markit says. More than half of the demand comes from Western Europe, driven by increasing regulation.
Vetter strikes out on new pathways to further develop the injection process. CDMO launches the Vetter Open Innovation Challenge under the slogan Injection 2.0′
https://european-biotechnology.com/wp-content/uploads/2024/04/Kick_Off_-_Vetter.jpg360640Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2018-07-31 12:40:342018-07-31 12:40:34Kick Off Vetter’s New Innovation Challenge
Swiss pharma giant Novartis announced that its monoclonal antibody for migraine prevention Aimovig (erenumab) has received market approval in the EU. It is the first treatment of its kind to be available here.
Spanish Capital Cell continues to be a pioneer in the health crowdfunding scene and launched a new self-funding fundraising round to create the first ICO marketplace for health via Blockchain.
A financing agreement with the European Investment Bank will allow the French cancer specialist Nanobiotix to borrow up to €40m through loan – money the company needs to boost its research, development and innovation activities.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB_DDheadshot.jpg700700Michael Kuhrt/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMichael Kuhrt2018-07-26 09:41:002018-07-26 09:41:00Morphosys launches US subsidiary, appoints lead
The EU Court of Justice has ruled that plants created using novel genome editing methods will be classed as genetically modified organisms and therefore have to follow the strict EU guidelines for GMOs.
https://european-biotechnology.com/wp-content/uploads/2024/04/20180725-gmo.jpg5631000Uta Mommert/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngUta Mommert2018-07-25 15:29:002018-07-25 15:29:00CRISPR & Co are GMOs, says EU court
Cell Medica Appoints New CEO
AppointmentsCell Medica, a company active in the development, manufacture and marketing of personalised cellular immunotherapeutics for the treatment of cancer, has appointed Chris Nowers as Chief Executive Officer and Executive Director.
ReViral raises US$55m
Latest NewsAntiviral drug discovery company ReViral announced the successful completion of a of a US$55m Series B financing. The funding will go toward clinical studies for its respiratory tract infection treatment.
EU’s single-use plastic rules boost bioplastics
Latest NewsThe global market value of biodegradable plastics has passed the US$1.1bn mark in 2018, a report by IHS Markit says. More than half of the demand comes from Western Europe, driven by increasing regulation.
Marinomed Biotech Appoints New CFO
AppointmentsPascal Schmidt appointed CFO as Vienna based biotech firm Marinomedas of August 1 2018.
Kick Off Vetter’s New Innovation Challenge
Sponsored PublicationsVetter strikes out on new pathways to further develop the injection process.
CDMO launches the Vetter Open Innovation Challenge under the slogan Injection 2.0′
First migraine prevention drug hits EU market
Latest NewsSwiss pharma giant Novartis announced that its monoclonal antibody for migraine prevention Aimovig (erenumab) has received market approval in the EU. It is the first treatment of its kind to be available here.
Crowdfunding goes blockchain
BackgroundSpanish Capital Cell continues to be a pioneer in the health crowdfunding scene and launched a new self-funding fundraising round to create the first ICO marketplace for health via Blockchain.
Nanobiotix signs €40m deal with EIB
Latest NewsA financing agreement with the European Investment Bank will allow the French cancer specialist Nanobiotix to borrow up to €40m through loan – money the company needs to boost its research, development and innovation activities.
Morphosys launches US subsidiary, appoints lead
AppointmentsMorphosys has named Jennifer Herron President of MorphoSys US Inc. to build up sales presence overseas.
CRISPR & Co are GMOs, says EU court
Latest NewsThe EU Court of Justice has ruled that plants created using novel genome editing methods will be classed as genetically modified organisms and therefore have to follow the strict EU guidelines for GMOs.